View Single Post
Old 12-06-2013, 05:44 PM   #4
A. L. Pendley
Join Date: Jul 2012
Posts: 14
Re: HKI-272 for HER2-Positive Breast Cancer and Brain Metastases

I'm interested in the HKI 272 Naratinib + Xeloda + Herceptin trial. I am currently in the Arry 380 trial which has a similar goal - to treat mets in the brain as well as in the rest of the system. I've been in the Arry 380 study now for 5 weeks and get my 6-week scans next week to see if I'm still included in the study (if I'm stable or improved). I want to stay on it, but if I can't, I hope Naratinib becomes another option. I'll be watching what others say on both of these trials! Ann
A. L. Pendley is offline   Reply With Quote